[HTML][HTML] Ovarian tumor microenvironment signaling: convergence on the Rac1 GTPase
LG Hudson, JM Gillette, H Kang, MR Rivera… - Cancers, 2018 - mdpi.com
The tumor microenvironment for epithelial ovarian cancer is complex and rich in bioactive
molecules that modulate cell-cell interactions and stimulate numerous signal transduction …
molecules that modulate cell-cell interactions and stimulate numerous signal transduction …
Visible-light-induced, catalyst and additive-free cycloaddition of vinylcyclopropanes: access to sulfur-containing seven-membered heterocycles
X Huang, R Wang, C Zhou, R Gao, H Zhang… - Organic Chemistry …, 2021 - pubs.rsc.org
Here we describe a visible-light-induced, catalyst and additive-free approach for the [5+ 2]
cycloadditions of vinylcyclopropanes (VCPs) with thioparabanates. This operationally simple …
cycloadditions of vinylcyclopropanes (VCPs) with thioparabanates. This operationally simple …
Ex vivo indocyanine green fluorescence imaging for the detection of lymph node involvement in advanced‐stage ovarian cancer
CF Pop, I Veys, M Gomez Galdon… - Journal of surgical …, 2018 - Wiley Online Library
Background and objectives The aim of this study was to evaluate the role of indocyanine
green (ICG) fluorescence imaging (FI) for the ex vivo detection of metastatic lymph nodes …
green (ICG) fluorescence imaging (FI) for the ex vivo detection of metastatic lymph nodes …
Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma
Z Yuan, A Xing, J Zheng, W Li - International Journal of …, 2019 - Taylor & Francis
Purpose: This study aimed to assess the safety and technical feasibility of percutaneous
ablation therapy for lymph node (LN) metastases of hepatocellular carcinoma (HCC) …
ablation therapy for lymph node (LN) metastases of hepatocellular carcinoma (HCC) …
[HTML][HTML] The role systematic lymphadenectomy plays in determining the survival outcome for advanced ovarian cancer patients: a meta-analysis
D Xu, J Xue, R Rozan, L Li - Annals of Palliative Medicine, 2020 - apm.amegroups.org
Background: This study aims to evaluate the role systematic lymphadenectomy (SL) plays in
advanced ovarian cancer (OC) patients. A meta-analysis was done to compare the …
advanced ovarian cancer (OC) patients. A meta-analysis was done to compare the …
Is the LION strong enough?
Ovarian cancer is the leading cause of gynecologic cancer related deaths worldwide [1]. The
treatment approach of advanced ovarian cancer relies on the complete resection of all …
treatment approach of advanced ovarian cancer relies on the complete resection of all …
Neo-adjuvant chemotherapy does not reduce surgical complexity nor the accuracy of intra-operative visual assessment of disease in advanced ovarian cancer
S Addley, M McGowan, H Crossland, A Johnson… - European Journal of …, 2023 - Elsevier
Aim Compare the surgical complexity and histological accuracy of visual inspection of
disease in patients undergoing primary debulking (PDS) versus delayed debulking surgery …
disease in patients undergoing primary debulking (PDS) versus delayed debulking surgery …
[HTML][HTML] US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report
G Tian, T Jiang - Medicine, 2017 - journals.lww.com
Interventions: Then this patient repeatedly received 4 ablations with US-guided laser
ablation within a month. Outcomes: After 4 ablations due to residual tumor, MR, and CT …
ablation within a month. Outcomes: After 4 ablations due to residual tumor, MR, and CT …
Reste-t-il des indications de curage ganglionnaire dans les cancers épithéliaux de l'ovaire après l'essai LION?
H Azaïs, G Canlorbe, M Nikpayam, C Gonthier… - Bulletin du …, 2020 - Elsevier
Résumé En mars 2019, Harter et al. publient les résultats de l'essai LION
(Lymphadenectomy in patients with advanced ovarian neoplasms) qui remettent en cause …
(Lymphadenectomy in patients with advanced ovarian neoplasms) qui remettent en cause …
[HTML][HTML] 不同转移路径对 III 期高级别浆液性卵巢癌预后的影响
夏梦瑶, 殷广洁, 孔琰, 孙铭泽, 吕菁菁… - Advances in Clinical …, 2023 - hanspub.org
目的: 分析不同转移路径对III 期高级别浆液性卵巢癌预后的影响. 方法: 回顾性统计2000~ 2020
年期间就诊于青岛大学附属医院符合纳入标准的III 期高级别浆液性卵巢癌患者. 根据转移路径 …
年期间就诊于青岛大学附属医院符合纳入标准的III 期高级别浆液性卵巢癌患者. 根据转移路径 …